FSD Pharma (OTC PINK: FSDDF) (HUGE.CN) reported its financial and operational results for the second quarter of fiscal 2018, ended June 30th, 2018. According to its filings, the company maintained a balance sheet with cash of $31,700,000, no debt, and stronger asset holdings. FSD is said to be aiming for a total grow capacity in excess of 3,000,000 square feet. The company also is expecting an annual output of 400,000,000 grams of which FSD Pharma would benefit 200,000,000 grams.